Saba Capital Management »

Carmell Therapeutics Corp - US shares owned by Saba Capital Management

Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCXW) shares owned by Saba Capital Management from 13F filings

Historical chart of Saba Capital Management investment in Carmell Therapeutics Corp - US

Tip: Access up to 7 years of quarterly data

All positions including Carmell Therapeutics Corp - US held by Saba Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carmell Therapeutics Corp - US by Saba Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.4k 20k 0.07
2024-03-31 $3.3k 20k 0.17
2023-12-31 $4.4k 20k 0.22
2023-09-30 $4.8k 20k 0.25

More positions owned by Saba Capital Management

Ishares Tr Russell 2000 Etf Call Option (IWM)
Blackrock Esg Cap Allc Term Shs Ben Int (ECAT)
Blackrock Innovation And Grw Shs Ben Int (BIGZ)
Blackrock Health Sciences Te Com Shs (BMEZ)
Blackrock Capital Allocation Trust (BCAT)
Adams Express Company (ADX)
Pimco Dynamic Income Strateg Com Shs Ben Int (PDX)
Blackrock Science & Technolo Shs Ben Int (BSTZ)
Nuveen CA Dividend Advantage Muni. Fund (NAC)
Gabelli Dividend & Income Trust (GDV)
Mainstay Cbre Global (MEGI)
Nuveen Nj Div Advantage Mun (NXJ)
Neuberger Berman Next Genera Common Stock (NBXG)
American Airls Put Option (AAL)
Invesco Van Kampen Muni Opp Trust (VMO)

View all positions for Saba Capital Management

Top funds holding Carmell Therapeutics Corp - US

Antara Capital
Balyasny Asset Management
OZ Management
Highbridge Capital Management
CNH Partners
Exos Asset Management
Citadel Advisors
Saba Capital Management
Whitebox Advisors
Clear Street
Ancora Advisors
Wolverine Asset Management
Bank of America Corporation

View all funds holding Carmell Therapeutics Corp - US